Home » Keywords » Iressa. Items Tagged with 'Iressa' ARTICLES. FDA gives thumbs up to Foundationone Liquid CDx. Aug. 27, 2020. By Liz Hollis. No Comments. Foundation Medicine Inc.’s string of 2020 ...

said Monday that its experimental cancer drug, Iressa, when given with standard chemotherapy, failed to improve the survival rate of lung cancer patients in two large, late-stage clinical trials ...

The effect of EGF stimulation and its inhibition with gefitinib (‘Iressa’, ZD1839), an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, has been investigated in two EGFR ...

To assess the level of activity and toxicity of gefitinib (ZD1839, Iressa™) in a population of patients with locally recurrent and/or metastatic head and neck cancer. Patients were recruited ...

AstraZeneca Plc's cancer pill Iressa has been recommended for use in the National Health Service (NHS) after the drugmaker agreed an unusual fixed cost deal.

AstraZeneca's <AZN.L> cancer drug Iressa should be considered as a first-line therapy for non-smoking Asian patients who develop a common type of lung cancer, researchers said on Monday.

Iressa® is the kind of treatment that oncologists dream of - a pill that can be swallowed once a day, a non-toxic therapy that causes few side effects.

Iressa® is the kind of treatment that oncologists dream of - a pill that can be swallowed once a day, a non-toxic therapy that causes few side effects. Advanced Search. Home; News Releases; ...

May 27, 2003 — Editor's Note: On May 5, the U.S. Food and Drug Administration (FDA) approved AstraZeneca's gefitinib (Iressa) for non-small cell lung cancer that has progressed despite treatment ...

Iressa and its competitors are just one of the many new ideas that so excite cancer doctors these days. All are built on 30 years of research into the basic biology of tumors, ...